Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histopathologic changes in retinoblastoma after chemoreduction.

S Dithmar1, T M Aabert, H E Grossniklaus

  • 1Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, USA.

Retina (Philadelphia, Pa.)
|March 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semi-automated quantification of vitreal hyperreflective foci in SD-OCT and their relevance in patients with peripheral retinal breaks.

BMC ophthalmology·2023
Same author

[COVID-19-associated acute macular neuroretinopathy].

Die Ophthalmologie·2022
Same author

Transpupillary collagen photocrosslinking for targeted modulation of ocular biomechanics.

Biomaterials·2021
Same author

Analysis of Damage and Wound Healing in the Retinal Pigmented Epithelium.

Advances in experimental medicine and biology·2019
Same author

[Lymphoma of Ocular and Periocular Tissues - Clinicopathological Correlations].

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.

Journal of controlled release : official journal of the Controlled Release Society·2016
Same journal

Persistent placoid maculopathy: long term outcomes and prognostic factors.

Retina (Philadelphia, Pa.)·2026
Same journal

ANTI-VEGF THERAPY SWITCHING RETINAL DISEASES: Characterizing Clinical Manifestations and Common Involved Genes: ERRATUM.

Retina (Philadelphia, Pa.)·2026
Same journal

THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.

Retina (Philadelphia, Pa.)·2026
Same journal

EVALUATING CLINICAL OUTCOMES OF AMNIOTIC MEMBRANE COVERAGE COMBINED WITH EARLY VITRECTOMY IN THE MANAGEMENT OF PERFORATING GLOBE INJURIES.

Retina (Philadelphia, Pa.)·2026
Same journal

Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.

Retina (Philadelphia, Pa.)·2026
Same journal

Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.

Retina (Philadelphia, Pa.)·2026
See all related articles

Chemoreduction therapy for retinoblastoma shows varied effects. Histologic examination of enucleated eyes revealed diverse patterns, including gliotic masses and necrosis, despite a clinical type 3 regression pattern.

Area of Science:

  • Ophthalmology
  • Oncology
  • Pathology

Background:

  • Bilateral retinoblastoma requires effective treatment strategies.
  • Chemoreduction therapy is a primary approach for managing retinoblastoma.
  • Understanding histologic changes post-chemoreduction is crucial for treatment assessment.

Observation:

  • Two patients with bilateral retinoblastoma received chemoreduction therapy (carboplatin, vincristine, etoposide) followed by enucleation.
  • Both eyes displayed a clinical type 3 regression pattern.
  • Histopathologic analysis revealed distinct findings in each enucleated eye.

Findings:

  • One eye showed a gliotic mass with calcifications.
  • The other eye exhibited necrotic tumor adjacent to viable retinoblastoma.

Related Experiment Videos

  • These findings highlight the variable histologic responses to chemoreduction.

    • Implications:

    • Chemoreduction therapy can induce diverse histologic changes in retinoblastoma.
    • The clinical type 3 regression pattern corresponds to multiple histopathologic outcomes.
    • Further research is needed to correlate specific histologic findings with treatment response and prognosis.